Survival of Beneficial Vaginal Lactobacilli (BVL) to Different Gastrointestinal Tract Conditions

Author(s): Antonella Marchesi, Jessica A. Silva, Birgitt Wiese, María E.F. Nader-Macías*

Journal Name: Current Pharmaceutical Design

Volume 26 , Issue 29 , 2020


Become EABM
Become Reviewer
Call for Editor

Abstract:

Background: Lactobacilli are the dominant bacteria in the healthy vaginal tract, preventing the income of pathogenic microorganisms, either sexually or not transmitted. Probiotics are used to restore the vaginal microbiome by local administration. However, the ascendant colonization is proposed as a way to restore the vaginal balance, and to exert some complementary effects on the host, situation that requires that probiotic strains resist the gastrointestinal tract passage.

Objective: To determine which probiotic vaginal strains were able to resist different gastrointestinal factors (pH, bile salts, and enzymes) to advance in the design of oral formulas.

Methods: Different protocols were applied to evaluate the growth of 24 beneficial vaginal lactic bacteria (BVL) strains at low pH and high bile salts (individually evaluated) and in combined protocols. The viability of the strains in simulated gastrointestinal tract conditions was studied to select the most resistant strains.

Results: A low number of BVL was able to grow at low pH. Most of the strains did not survive at high bile salts concentration. The passage through pH first and bile salts later showed that only three strains were able to survive. In the simulated intestinal conditions, only Lactobacillus gasseri CRL1290, L. jensenii CRL1313, and L. jensenii CRL1349 decrease one or two logarithmic growth units (UFC/ml) at the end of the assay, maintaining their beneficial properties.

Conclusion: The behavior of BVL in the conditions assayed is not related to specific strain or metabolic group, because the resistance is strain-specific. The results highlight the importance of the screening performed in a way to select the most adequate strains to be included in the oral designed formula for the restoration of the vaginal tract microbiome.

Keywords: Vaginal lactobacilli, beneficial properties, gastrointestinal tract resistance, viability, ascendant colonization, vaginal tract microbiome.

[1]
Morgan P, Everett CM, Hing E. Time spent with patients by physicians, nurse practitioners, and physician assistants in community health centers, 2006-2010. Healthc (Amst) 2014; 2(4): 232-7.
[http://dx.doi.org/10.1016/j.hjdsi.2014.09.009] [PMID: 26250629]
[2]
Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature 2012; 486(7402): 207-14.
[http://dx.doi.org/10.1038/nature11234] [PMID: 22699609]
[3]
Romero R, Miranda J, Chaiworapongsa T, et al. Prevalence and clinical significance of sterile intra-amniotic inflammation in patients with preterm labor and intact membranes. Am J Reprod Immunol 2014; 72(5): 458-74.
[http://dx.doi.org/10.1111/aji.12296] [PMID: 25078709]
[4]
Huse SM, Ye Y, Zhou Y, Fodor AA. A core human microbiome as viewed through 16S rRNA sequence clusters. PLoS One 2012; 7(6) e34242
[http://dx.doi.org/10.1371/journal.pone.0034242] [PMID: 22719824]
[5]
Bisanz JE, Enos MK, PrayGod G, et al. Microbiota at Multiple Body Sites during Pregnancy in a Rural Tanzanian Population and Effects of Moringa-Supplemented Probiotic Yogurt. Appl Environ Microbiol 2015; 81(15): 4965-75.
[http://dx.doi.org/10.1128/AEM.00780-15] [PMID: 25979893]
[6]
Hill C, Guarner F, Reid G, et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 2014; 11(8): 506-14.
[http://dx.doi.org/10.1038/nrgastro.2014.66] [PMID: 24912386]
[7]
Sanders ME, Merenstein DJ, Reid G, Gibson GR, Rastall RA. Probiotics and prebiotics in intestinal health and disease: from biology to the clinic. Nat Rev Gastroenterol Hepatol 2019; 16(10): 605-16.
[http://dx.doi.org/10.1038/s41575-019-0173-3] [PMID: 31296969]
[8]
Ballini A, Santacroce L, Cantore S, et al. Probiotics Improve Urogenital Health in Women. Open Access Maced J Med Sci 2018; 6(10): 1845-50.
[http://dx.doi.org/10.3889/oamjms.2018.406] [PMID: 30455760]
[9]
Nader-Macías ME, Juárez Tomás MS. Profiles and technological requirements of urogenital probiotics. Adv Drug Deliv Rev 2015; 92(92): 84-104.
[http://dx.doi.org/10.1016/j.addr.2015.03.016] [PMID: 25858665]
[10]
Piqué N, Berlanga M, Miñana-Galbis D. Health Benefits of Heat-Killed (Tyndallized) Probiotics: An Overview. Int J Mol Sci 2019; 20(10) E2534
[http://dx.doi.org/10.3390/ijms20102534] [PMID: 31126033]
[11]
Johnson-Henry KC, Abrahamsson TR, Wu RY, Sherman PM. Probiotics, prebiotics, and synbiotics for the prevention of necrotizing enterocolitis. Adv Nutr 2016; 7(5): 928-37.
[http://dx.doi.org/10.3945/an.116.012237] [PMID: 27633108]
[12]
Patrignani F, Siroli L, Parolin C, Serrazanetti DI, Vitali B, Lanciotti R. Use of Lactobacillus crispatus to produce a probiotic cheese as potential gender food for preventing gynaecological infections. PLoS One 2019; 14(1) e0208906
[http://dx.doi.org/10.1371/journal.pone.0208906] [PMID: 30625157]
[13]
Lagenaur LA, Lee PP, Hamer DH, Sanders-Beer BE. Demonstration of vaginal colonization with GusA-expressing Lactobacillus jensenii following oral delivery in rhesus macaques. Res Microbiol 2011; 162(10): 1006-10.
[http://dx.doi.org/10.1016/j.resmic.2011.08.003] [PMID: 21907793]
[14]
Pospiech A, Neumann B. A versatile quick-prep of genomic DNA from gram-positive bacteria. Trends Genet 1995; 11(6): 217-8.
[http://dx.doi.org/10.1016/S0168-9525(00)89052-6] [PMID: 7638902]
[15]
Juárez Tomás MS, De Gregorio PR, Leccese Terraf MC, Nader-Macías ME. Encapsulation and subsequent freeze-drying of Lactobacillus reuteri CRL 1324 for its potential inclusion in vaginal probiotic formulations. Eur J Pharm Sci 2015; 79: 87-95.
[http://dx.doi.org/10.1016/j.ejps.2015.08.010] [PMID: 26299342]
[16]
Vera Pingitore E, Bru E, Elena Nader-Macías MI. Effect of lyophilization and storage temperature on the activity of salivaricin CRL 1328, a potential bioactive ingredient of a urogenital probiotic product. J Gen Appl Microbiol 2012; 58(2): 71-81.
[http://dx.doi.org/10.2323/jgam.58.71] [PMID: 22688238]
[17]
De Gregorio PR, Juárez Tomás MS, Leccese Terraf MC, Nader-Macías ME. Preventive effect of Lactobacillus reuteri CRL1324 on Group B Streptococcus vaginal colonization in an experimental mouse model. J Appl Microbiol 2015; 118(4): 1034-47.
[http://dx.doi.org/10.1111/jam.12739] [PMID: 25786121]
[18]
Vera Pingitore E, Juárez Tomás MS, Wiese B, Nader-Macías ME. Design of novel urogenital pharmabiotic formulations containing lactobacilli, salivaricin CRL 1328 and non-microbial compounds with different functionalities. Drug Dev Ind Pharm 2015; 41(6): 942-52.
[http://dx.doi.org/10.3109/03639045.2014.917092] [PMID: 24827975]
[19]
Juárez Tomás MS, Wiese B, Nader-Macías ME. Effects of culture conditions on the growth and auto-aggregation ability of vaginal Lactobacillus johnsonii CRL 1294. J Appl Microbiol 2005; 99(6): 1383-91.
[http://dx.doi.org/10.1111/j.1365-2672.2005.02726.x] [PMID: 16313411]
[20]
De Gregorio PR, Juárez Tomás MS, Leccese Terraf MC, Nader-Macías ME. In vitro and in vivo effects of beneficial vaginal lactobacilli on pathogens responsible for urogenital tract infections. J Med Microbiol 2014; 63(Pt 5): 685-96.
[http://dx.doi.org/10.1099/jmm.0.069401-0] [PMID: 24523160]
[21]
Leccese Terraf MC, Mendoza LM, Juárez Tomás MS, Silva C, Nader-Macías ME. Phenotypic surface properties (aggregation, adhesion and biofilm formation) and presence of related genes in beneficial vaginal lactobacilli. J Appl Microbiol 2014; 117(6): 1761-72.
[http://dx.doi.org/10.1111/jam.12642] [PMID: 25195810]
[22]
Zárate G, Sáez GD, Pérez Chaia A. Dairy propionibacteria prevent the proliferative effect of plant lectins on SW480 cells and protect the metabolic activity of the intestinal microbiota in vitro. Anaerobe 2017; 44: 58-65.
[http://dx.doi.org/10.1016/j.anaerobe.2017.01.012] [PMID: 28161414]
[23]
Strus M, Chmielarczyk A, Kochan P, et al. Studies on the effects of probiotic Lactobacillus mixture given orally on vaginal and rectal colonization and on parameters of vaginal health in women with intermediate vaginal flora. Eur J Obstet Gynecol Reprod Biol 2012; 163(2): 210-5.
[http://dx.doi.org/10.1016/j.ejogrb.2012.05.001] [PMID: 22721635]
[24]
Wang J, Ji H, Wang S, et al. Probiotic Lactobacillus plantarum Promotes Intestinal Barrier Function by Strengthening the Epithelium and Modulating Gut Microbiota. Front Microbiol 2018; 9: 1953.
[http://dx.doi.org/10.3389/fmicb.2018.01953] [PMID: 30197632]
[25]
Wu C, Huang J, Zhou R. Progress in engineering acid stress resistance of lactic acid bacteria. Appl Microbiol Biotechnol 2014; 98(3): 1055-63.
[http://dx.doi.org/10.1007/s00253-013-5435-3] [PMID: 24337395]
[26]
De Angelis M, Gobbetti M. Environmental stress responses in Lactobacillus: a review. Proteomics 2004; 4(1): 106-22. [Review].
[http://dx.doi.org/10.1002/pmic.200300497] [PMID: 14730676]
[27]
Yeo S, Park H, Ji Y, et al. Influence of gastrointestinal stress on autoinducer-2 activity of two Lactobacillus species. FEMS Microbiol Ecol 2015; 91(7) fiv065
[http://dx.doi.org/10.1093/femsec/fiv065] [PMID: 26092949]
[28]
Papadimitriou K, Alegría Á, Bron PA, et al. Stress Physiology of Lactic Acid Bacteria. Microbiol Mol Biol Rev 2016; 80(3): 837-90.
[http://dx.doi.org/10.1128/MMBR.00076-15] [PMID: 27466284]
[29]
Maldonado-Valderrama J, Wilde P, Macierzanka A, Mackie A. The role of bile salts in digestion. Adv Colloid Interface Sci 2011; 165(1): 36-46.
[http://dx.doi.org/10.1016/j.cis.2010.12.002]
[30]
Long SL, Gahan CGM, Joyce SA. Interactions between gut bacteria and bile in health and disease. Mol Aspects Med 2017; 56: 54-65.
[http://dx.doi.org/10.1016/j.mam.2017.06.002] [PMID: 28602676]
[31]
Bron PA, Marco M, Hoffer SM, Van Mullekom E, de Vos WM, Kleerebezem M. Genetic characterization of the bile salt response in Lactobacillus plantarum and analysis of responsive promoters in vitro and in situ in the gastrointestinal tract. J Bacteriol 2004; 186(23): 7829-35.
[http://dx.doi.org/10.1128/JB.186.23.7829-7835.2004] [PMID: 15547253]
[32]
Lv LX, Yan R, Shi HY, et al. Integrated transcriptomic and proteomic analysis of the bile stress response in probiotic Lactobacillus salivarius LI01. J Proteomics 2017; 150: 216-29.
[http://dx.doi.org/10.1016/j.jprot.2016.08.021] [PMID: 27585996]
[33]
Ruiz L, Margolles A, Sánchez B. Bile resistance mechanisms in Lactobacillus and Bifidobacterium. Front Microbiol 2013; 4: 396.
[http://dx.doi.org/10.3389/fmicb.2013.00396]
[34]
Maldonado NC, de Ruiz CS, Otero MC, Sesma F, Nader-Macías ME. Lactic acid bacteria isolated from young calves-characteri-zation and potential as probiotics. Res Vet Sci 2012; 92(2): 342-9.
[http://dx.doi.org/10.1016/j.rvsc.2011.03.017] [PMID: 21497871]
[35]
Sánchez L, Omura M, Lucas A, Pérez T, Llanes M, Ferreira CDL. Cepas de Lactobacillus spp. con capacidades probióticas aisladas del tracto intestinal de terneros neonatos. Rev Salud Anim 2015; 37(2): 94-104.
[36]
de Champs C, Maroncle N, Balestrino D, Rich C, Forestier C. Persistence of colonization of intestinal mucosa by a probiotic strain, Lactobacillus casei subsp. rhamnosus Lcr35, after oral consumption. J Clin Microbiol 2003; 41(3): 1270-3.
[http://dx.doi.org/10.1128/JCM.41.3.1270-1273.2003] [PMID: 12624065]
[37]
Amund OD. Exploring the relationship between exposure to technological and gastrointestinal stress and probiotic functional properties of lactobacilli and bifidobacteria. Can J Microbiol 2016; 62(9): 715-25.
[http://dx.doi.org/10.1139/cjm-2016-0186] [PMID: 27461506]
[38]
Arnold JW, Simpson JB, Roach J, Kwintkiewicz J, Azcarate-Peril MA. Intra-species Genomic and Physiological Variability Impact Stress Resistance in Strains of Probiotic Potential. Front Microbiol 2018; 9: 242.
[http://dx.doi.org/10.3389/fmicb.2018.00242] [PMID: 29515537]
[39]
El Aila NA, Tency I, Claeys G, et al. Identification and genotyping of bacteria from paired vaginal and rectal samples from pregnant women indicates similarity between vaginal and rectal microflora. BMC Infect Dis 2009; 9: 167.
[http://dx.doi.org/10.1186/1471-2334-9-167] [PMID: 19828036]
[40]
Antonio MA, Rabe LK, Hillier SL. Colonization of the rectum by Lactobacillus species and decreased risk of bacterial vaginosis. J Infect Dis 2005; 192(3): 394-8.
[http://dx.doi.org/10.1086/430926] [PMID: 15995952]
[41]
Yang B, Chen Y, Stanton C, et al. Bifidobacterium and Lactobacillus Composition at Species Level and Gut Microbiota Diversity in Infants before 6 Weeks. Int J Mol Sci 2019; 20(13) E3306
[http://dx.doi.org/10.3390/ijms20133306] [PMID: 31284413]


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 26
ISSUE: 29
Year: 2020
Published on: 03 September, 2020
Page: [3608 - 3618]
Pages: 11
DOI: 10.2174/1381612826666200218093607
Price: $65

Article Metrics

PDF: 29
HTML: 3